Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide and Dexamethasone in AL Amyloidosis
NCT01570387Phase 2Completed
- Sponsor
- Boston Medical Center
- Start
- Jun 2012
- Primary completion
- Nov 2018
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in amyloid light chain amyloidosis, sponsored by Boston Medical Center. Started Jun 2012; status: completed.
02
Drugs
pomalidomide
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT01570387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01570387.